What question did this study set out to answer?

To evaluate the rates of recurrence of basal cell carcinoma following hypofractionated kilovoltage radiotherapy treatment.

April 14, 2026

Clinically relevant recurrence of basal cell carcinoma following primary treatment with hypofractionated kilovoltage radiotherapy: A single-centre retrospective review

Puntos clave

To evaluate the rates of recurrence of basal cell carcinoma following hypofractionated kilovoltage radiotherapy treatment.
Retrospective review of 287 patients treated for basal cell carcinoma
Evaluated recurrence rates over a 3-year follow-up period
Focused on patients receiving hypofractionated radiotherapy
Out of 287 treated basal cell carcinomas, 8 recurrences were noted
Recurrence rate was 2.8% within 3 years following treatment
Indicates a low rate of clinically relevant recurrence for the treatment modality

Resumen

Basal cell carcinoma (BCC) is the most common type of skin cancer, for which national guidance recommends surgical excision first-line, though superficial radiotherapy can be offered as a non-invasive alternative. Our study retrospectively evaluated patients for 3 years following radiotherapy to treat primary BCC to establish rates of recurrence. Of 287 treated BCCs, there were 8 recurrences (2.8%) within 3 years of treatment.

Preguntar a la IA

Me gusta

Guardar